CD8+ EFFECTOR CELLS RESPONDING TO RESIDUAL CLASS I ANTIGENS, WITH HELP FROM CD4+ CELLS STIMULATED INDIRECTLY, CAUSE REJECTION OF ???MAJOR HISTOCOMPATIBILITY COMPLEX-DEFICIENT??? SKIN GRAFTS1
- 1 April 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 63 (8) , 1123-1133
- https://doi.org/10.1097/00007890-199704270-00012
Abstract
Skin grafts from mice that are deficient in the expression of both class I and class II major histocompatibility complex (MHC) antigens are rejected rapidly by normal recipients. To determine the mechanism of this rejection, MHC-deficient skin grafts were placed on recipients with different degrees of antigenic disparity and on recipients depleted of selected T cell subpopulations. In addition, the recipient's T cells were examined in vitro for their responses before and after graft rejection. The results indicate that (1) CD4+ cells provide help for this rejection by recognizing donor antigens presented by recipient class II antigens, and (2) CD8+ cells can participate as effector cells, recognizing residual class I antigens expressed by the MHC-dificient grafts. The primary conclusion from these studies is that the supposedly MHC-deficient mice actually do have sufficient class I antigen expression to cause skin graft rejection. This finding prevents the use of these mice to answer definitively the question of whether grafts entirely lacking MHC antigens would be rejected. However, these studies do illustrate two important (although previously recognized) features of allogeneic skin graft rejection: (1) that rejection can be initiated by help provided entirely through the indirect pathway, and (2) that help provided through the indirect pathway is available for effector T cells sensitized directly by donor cells. However, the results from these and other studies suggest that indirect effector mechanisms would probably be able to destroy truly MHC-deficient grafts under some circumstances.Keywords
This publication has 31 references indexed in Scilit:
- Survival Of Mhc-Deficient Mouse Heterotopic Cardiac AllograftsTransplantation, 1995
- Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts.The Journal of Experimental Medicine, 1994
- CURRENT LIMITATIONS TO USE OF MAJOR HISTOCOMPATIBILITY COMPLEX TRANSGENIC DONORS FOR ISLET TRANSPLANTATIONTransplantation, 1994
- USE OF DONOR β2-MICROGLOBULIN-DEFICIENT TRANSGENIC MOUSE LIVER CELLS FOR ISOGRAFTS, ALLOGRAFTS, AND XENOGRAFTSTransplantation, 1993
- INDEFINITE SURVIVAL OF MHC CLASS I-DEFICIENT MURINE PANCREATIC ISLET ALLOGRAFTSTransplantation, 1992
- Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells.The Journal of Experimental Medicine, 1992
- In Vivo use of monoclonal antibodies against murine T cell antigensClinical Immunology and Immunopathology, 1989
- Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.The Journal of Experimental Medicine, 1988
- Antigen-specific interaction between T and B cellsNature, 1985
- Cross‐blocking studies with monoclonal antibodies against I‐A molecules of haplotypes b, d and kEuropean Journal of Immunology, 1982